Correlation Between Medicofarma Biotech and Dino Polska

Can any of the company-specific risk be diversified away by investing in both Medicofarma Biotech and Dino Polska at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Medicofarma Biotech and Dino Polska into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Medicofarma Biotech SA and Dino Polska SA, you can compare the effects of market volatilities on Medicofarma Biotech and Dino Polska and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Medicofarma Biotech with a short position of Dino Polska. Check out your portfolio center. Please also check ongoing floating volatility patterns of Medicofarma Biotech and Dino Polska.

Diversification Opportunities for Medicofarma Biotech and Dino Polska

-0.85

Correlation Coefficient

Medicofarma Biotech  Dino Polska

Pay attention - limited upside

The 3 months correlation between Medicofarma and Dino is -0.85. Overlapping area represents the amount of risk that can be diversified away by holding Medicofarma Biotech SA and Dino Polska SA in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Dino Polska SA and Medicofarma Biotech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Medicofarma Biotech SA are associated (or correlated) with Dino Polska. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Dino Polska SA has no effect on the direction of Medicofarma Biotech i.e., Medicofarma Biotech and Dino Polska go up and down completely randomly.

Pair Corralation between Medicofarma Biotech and Dino Polska

Assuming the 90 days trading horizon Medicofarma Biotech SA is expected to under-perform the Dino Polska. In addition to that, Medicofarma Biotech is 3.19 times more volatile than Dino Polska SA. It trades about -0.09 of its total potential returns per unit of risk. Dino Polska SA is currently generating about 0.24 per unit of volatility. If you would invest  39,120  in Dino Polska SA on December 2, 2024 and sell it today you would earn a total of  10,440  from holding Dino Polska SA or generate 26.69% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Significant
Accuracy	98.33%
Values	Daily Returns

Medicofarma Biotech SA  vs.  Dino Polska SA

Medicofarma Biotech

Risk-Adjusted Performance

Very Weak

Over the last 90 days Medicofarma Biotech SA has generated negative risk-adjusted returns adding no value to investors with long positions. Even with weak performance in the last few months, the Stock's basic indicators remain relatively invariable which may send shares a bit higher in April 2025. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors.

Dino Polska SA

Risk-Adjusted Performance

Solid

Compared to the overall equity markets, risk-adjusted returns on investments in Dino Polska SA are ranked lower than 19 (%) of all global equities and portfolios over the last 90 days. Even with relatively weak basic indicators, Dino Polska reported solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Medicofarma Biotech and Dino Polska

The main advantage of trading using opposite Medicofarma Biotech and Dino Polska positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Medicofarma Biotech position performs unexpectedly, Dino Polska can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Dino Polska will offset losses from the drop in Dino Polska's long position.

The idea behind Medicofarma Biotech SA and Dino Polska SA pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.